Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Name: Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
Published: 2023
License: Public Domain

AstraZeneca · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

chronic-obstructive-pulmonary-disease copd

chronic obstructive pulmonary disease (copd), chronic obstructive pulmonary disease, copd, tozorakimab, medi3506, exacerbations, ics, laba/lama, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Related documents